Zomedica ZOMDF
OTC ZOMDF
$0.10 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Zomedica (ZOMDF) Cash from Investing Activities (2017 - 2026)

Updated

Zomedica (ZOMDF) posted Cash from Investing Activities of $2.84 million for Q3 2026, down 29.8% from $4.04 million a year earlier but up 634.7% from the prior quarter.

Analysis

Zomedica (ZOMDF) Cash from Investing Activities (2017 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cash from Investing Activities at Zomedica was $11.29 million, down 40.7% year-over-year; for FY2025, it came in at $19.58 million, up 9.6% from FY2024.

  • Annual Cash from Investing Activities shows a five-year compound annual growth rate of 81.1% (FY2020 to FY2025).
  • In prior years, Zomedica's Cash from Investing Activities was $17.85 million in FY2024, $1.58 million in FY2023, -$155.88 million in FY2022 and -$71.93 million in FY2021.
  • Quarterly Cash from Investing Activities has run from a low of -$138.89 million in Q3 2022 to a high of $23.32 million in Q2 2023 over five years.
  • On a year-over-year basis, Cash from Investing Activities has declined in each of the last three quarters, with an average decline of 13.1% over the last seven quarters.
  • The strongest year-over-year quarter for Cash from Investing Activities in the past five years was Q1 2025, with growth of 49.4%; the weakest was Q2 2026, with a decline of 91.8%.
  • According to Business Quant data, Cash from Investing Activities for the three prior quarters was $386,000 (Q2 2026), $5.62 million (Q1 2026) and $2.45 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -8.30 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -2.71 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -10.22 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -1.32 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -1.89 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn -649.00 Mn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -244.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -2.03 Bn
10 Zomedica 97.99 Mn -87.03 Mn 6.04 Mn 2.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.84 Mn
Jun 30, 2026 386,000.00
Mar 31, 2026 5.62 Mn
Dec 31, 2025 2.45 Mn
Sep 30, 2025 4.04 Mn
Jun 30, 2025 4.68 Mn
Mar 31, 2025 8.41 Mn
Dec 31, 2024 1.92 Mn
Sep 30, 2024 6.54 Mn
Jun 30, 2024 3.77 Mn
Mar 31, 2024 5.63 Mn
Dec 31, 2023 -3.83 Mn
Sep 30, 2023 -3.12 Mn
Jun 30, 2023 23.32 Mn
Mar 31, 2023 -14.79 Mn
Dec 31, 2022 -15.35 Mn
Sep 30, 2022 -138.89 Mn
Jun 30, 2022 -1.44 Mn
Mar 31, 2022 -206,000.00
Dec 31, 2021 -71.58 Mn
API Access

Zomedica Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ZOMDF&period=max&api_key=YOUR_API_KEY